HEADER OXIDOREDUCTASE 18-MAR-15 4YU1 TITLE HUMAN ALDOSE REDUCTASE COMPLEXED WITH SCHL12134 (3-[5-(3-NITROPHENYL)- TITLE 2 2-THIENYL]PROPANOIC ACID) AT 1.02 A COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALDOSE REDUCTASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: AR,ALDEHYDE REDUCTASE,ALDO-KETO REDUCTASE FAMILY 1 MEMBER COMPND 5 B1; COMPND 6 EC: 1.1.1.21; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKR1B1, ALDR1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: GOLD; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS TIM-BARREL, OXIDOREDUCTASE, PROTEIN-LIGAND-COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.RECHLIN,A.HEINE,G.KLEBE REVDAT 2 10-JAN-24 4YU1 1 REMARK REVDAT 1 23-MAR-16 4YU1 0 JRNL AUTH C.RECHLIN,A.HEINE,R.ORTMANN,M.SCHLITZER,G.KLEBE JRNL TITL KEYS TO OPEN THE SPECIFICITY POCKET: BIPHENYLIC INHIBITORS JRNL TITL 2 OF THE HUMAN ALDOSE REDUCTASE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.02 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.4_1492) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.02 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.70 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 3 NUMBER OF REFLECTIONS : 150569 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.134 REMARK 3 R VALUE (WORKING SET) : 0.133 REMARK 3 FREE R VALUE : 0.150 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 7528 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 24.7117 - 3.1640 0.99 4977 262 0.1344 0.1569 REMARK 3 2 3.1640 - 2.5121 0.99 4931 259 0.1453 0.1635 REMARK 3 3 2.5121 - 2.1948 0.99 4915 259 0.1420 0.1483 REMARK 3 4 2.1948 - 1.9942 0.98 4871 256 0.1313 0.1418 REMARK 3 5 1.9942 - 1.8513 0.98 4866 257 0.1337 0.1547 REMARK 3 6 1.8513 - 1.7422 0.99 4902 258 0.1268 0.1292 REMARK 3 7 1.7422 - 1.6550 0.99 4856 255 0.1233 0.1279 REMARK 3 8 1.6550 - 1.5829 0.99 4891 258 0.1152 0.1318 REMARK 3 9 1.5829 - 1.5220 0.99 4876 256 0.1120 0.1312 REMARK 3 10 1.5220 - 1.4695 0.98 4851 255 0.1149 0.1419 REMARK 3 11 1.4695 - 1.4236 0.98 4841 255 0.1164 0.1256 REMARK 3 12 1.4236 - 1.3829 0.98 4811 253 0.1137 0.1534 REMARK 3 13 1.3829 - 1.3465 0.98 4837 255 0.1153 0.1387 REMARK 3 14 1.3465 - 1.3136 0.98 4772 251 0.1132 0.1327 REMARK 3 15 1.3136 - 1.2838 0.97 4802 253 0.1166 0.1340 REMARK 3 16 1.2838 - 1.2564 0.97 4780 251 0.1154 0.1347 REMARK 3 17 1.2564 - 1.2313 0.97 4767 251 0.1153 0.1469 REMARK 3 18 1.2313 - 1.2081 0.96 4725 249 0.1187 0.1497 REMARK 3 19 1.2081 - 1.1865 0.96 4739 250 0.1195 0.1286 REMARK 3 20 1.1865 - 1.1664 0.96 4753 250 0.1187 0.1437 REMARK 3 21 1.1664 - 1.1476 0.96 4705 247 0.1215 0.1383 REMARK 3 22 1.1476 - 1.1299 0.95 4706 248 0.1261 0.1313 REMARK 3 23 1.1299 - 1.1133 0.95 4721 248 0.1402 0.1865 REMARK 3 24 1.1133 - 1.0976 0.96 4683 246 0.1550 0.1648 REMARK 3 25 1.0976 - 1.0828 0.95 4621 244 0.1554 0.1617 REMARK 3 26 1.0828 - 1.0687 0.95 4725 248 0.1673 0.1773 REMARK 3 27 1.0687 - 1.0554 0.95 4612 243 0.1864 0.1920 REMARK 3 28 1.0554 - 1.0426 0.94 4652 245 0.1973 0.2171 REMARK 3 29 1.0426 - 1.0305 0.94 4548 239 0.2095 0.2504 REMARK 3 30 1.0305 - 1.0189 0.87 4305 227 0.2353 0.2408 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.070 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 12.870 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2803 REMARK 3 ANGLE : 1.371 3852 REMARK 3 CHIRALITY : 0.088 428 REMARK 3 PLANARITY : 0.010 509 REMARK 3 DIHEDRAL : 13.856 1054 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4YU1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-MAR-15. REMARK 100 THE DEPOSITION ID IS D_1000208081. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-FEB-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 150587 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.020 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04900 REMARK 200 FOR THE DATA SET : 14.0200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.02 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.08 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.480 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2DUX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALLIZATION SOLUTION: 50 MM DI REMARK 280 -AMMONIUMHYDROGEN CITRATE PH 5.0 PEG6000= 5 % (M/V) DTT= 5.15 G/ REMARK 280 L NADP+= 0.66 G/L AND HUMAN ALDOSE REDUCTASE= 15 MG/ REMARK 280 ML.AFTERWARDS THE CRYSTALS WERE SOAKED INTO TRIS 100 MM 25% (M/V) REMARK 280 PEG6000 PH 8.0 SATURATED WITH THE INHIBITOR., VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.17700 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1220 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12940 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 68 CE NZ REMARK 470 GLU A 70 CD OE1 OE2 REMARK 470 LYS A 85 CG CD CE NZ REMARK 470 LYS A 116 NZ REMARK 470 LYS A 119 CE NZ REMARK 470 GLU A 126 CG CD OE1 OE2 REMARK 470 ASN A 136 CG OD1 ND2 REMARK 470 LYS A 194 CG CD CE NZ REMARK 470 LYS A 221 CD CE NZ REMARK 470 LYS A 234 NZ REMARK 470 GLU A 267 CD OE1 OE2 REMARK 470 LEU A 301 CG CD1 CD2 REMARK 470 GLU A 313 CD OE1 OE2 REMARK 470 GLU A 314 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY A 25 O - C - N ANGL. DEV. = -9.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 21 -2.75 78.81 REMARK 500 LEU A 190 80.48 -150.33 REMARK 500 ARG A 293 16.39 -143.85 REMARK 500 ALA A 299 118.91 -169.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 GLY A 25 -18.95 REMARK 500 GLY A 25 -18.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 728 DISTANCE = 5.98 ANGSTROMS REMARK 525 HOH A 773 DISTANCE = 7.48 ANGSTROMS REMARK 525 HOH A 782 DISTANCE = 6.71 ANGSTROMS REMARK 525 HOH A 783 DISTANCE = 6.27 ANGSTROMS REMARK 525 HOH A 784 DISTANCE = 6.78 ANGSTROMS REMARK 525 HOH A 787 DISTANCE = 5.98 ANGSTROMS REMARK 525 HOH A 789 DISTANCE = 6.20 ANGSTROMS REMARK 525 HOH A 790 DISTANCE = 8.10 ANGSTROMS REMARK 525 HOH A 791 DISTANCE = 8.33 ANGSTROMS REMARK 525 HOH A 792 DISTANCE = 10.05 ANGSTROMS REMARK 525 HOH A 793 DISTANCE = 10.78 ANGSTROMS REMARK 525 HOH A 806 DISTANCE = 8.46 ANGSTROMS REMARK 525 HOH A 809 DISTANCE = 7.92 ANGSTROMS REMARK 525 HOH A 823 DISTANCE = 8.76 ANGSTROMS REMARK 525 HOH A 848 DISTANCE = 7.89 ANGSTROMS REMARK 525 HOH A 851 DISTANCE = 6.25 ANGSTROMS REMARK 525 HOH A 859 DISTANCE = 6.79 ANGSTROMS REMARK 525 HOH A 864 DISTANCE = 7.67 ANGSTROMS REMARK 525 HOH A 882 DISTANCE = 7.34 ANGSTROMS REMARK 525 HOH A 895 DISTANCE = 6.58 ANGSTROMS REMARK 525 HOH A 906 DISTANCE = 6.90 ANGSTROMS REMARK 525 HOH A 911 DISTANCE = 6.04 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAP A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 53N A 402 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2IKG RELATED DB: PDB REMARK 900 HUMAN ALDOSE REDUCTASE COMPLEXED WITH ANOTHER INHIBITOR FROM THE REMARK 900 SAME GROUP. REMARK 900 RELATED ID: 2IKH RELATED DB: PDB REMARK 900 HUMAN ALDOSE REDUCTASE COMPLEXED WITH ANOTHER INHIBITOR FROM THE REMARK 900 SAME GROUP. REMARK 900 RELATED ID: 3DN5 RELATED DB: PDB REMARK 900 HUMAN ALDOSE REDUCTASE COMPLEXED WITH ANOTHER INHIBITOR FROM THE REMARK 900 SAME GROUP. REMARK 900 RELATED ID: 4NKC RELATED DB: PDB REMARK 900 HUMAN ALDOSE REDUCTASE COMPLEXED WITH ANOTHER INHIBITOR FROM THE REMARK 900 SAME GROUP. REMARK 900 RELATED ID: 4PR4 RELATED DB: PDB REMARK 900 HUMAN ALDOSE REDUCTASE COMPLEXED WITH ANOTHER INHIBITOR FROM THE REMARK 900 SAME GROUP. REMARK 900 RELATED ID: 4PRR RELATED DB: PDB REMARK 900 HUMAN ALDOSE REDUCTASE COMPLEXED WITH ANOTHER INHIBITOR FROM THE REMARK 900 SAME GROUP. REMARK 900 RELATED ID: 4PRT RELATED DB: PDB REMARK 900 HUMAN ALDOSE REDUCTASE COMPLEXED WITH ANOTHER INHIBITOR FROM THE REMARK 900 SAME GROUP. DBREF 4YU1 A 0 315 UNP P15121 ALDR_HUMAN 1 316 SEQADV 4YU1 ILE A 4 UNP P15121 LEU 5 CONFLICT SEQRES 1 A 316 MET ALA SER ARG ILE LEU LEU ASN ASN GLY ALA LYS MET SEQRES 2 A 316 PRO ILE LEU GLY LEU GLY THR TRP LYS SER PRO PRO GLY SEQRES 3 A 316 GLN VAL THR GLU ALA VAL LYS VAL ALA ILE ASP VAL GLY SEQRES 4 A 316 TYR ARG HIS ILE ASP CYS ALA HIS VAL TYR GLN ASN GLU SEQRES 5 A 316 ASN GLU VAL GLY VAL ALA ILE GLN GLU LYS LEU ARG GLU SEQRES 6 A 316 GLN VAL VAL LYS ARG GLU GLU LEU PHE ILE VAL SER LYS SEQRES 7 A 316 LEU TRP CYS THR TYR HIS GLU LYS GLY LEU VAL LYS GLY SEQRES 8 A 316 ALA CYS GLN LYS THR LEU SER ASP LEU LYS LEU ASP TYR SEQRES 9 A 316 LEU ASP LEU TYR LEU ILE HIS TRP PRO THR GLY PHE LYS SEQRES 10 A 316 PRO GLY LYS GLU PHE PHE PRO LEU ASP GLU SER GLY ASN SEQRES 11 A 316 VAL VAL PRO SER ASP THR ASN ILE LEU ASP THR TRP ALA SEQRES 12 A 316 ALA MET GLU GLU LEU VAL ASP GLU GLY LEU VAL LYS ALA SEQRES 13 A 316 ILE GLY ILE SER ASN PHE ASN HIS LEU GLN VAL GLU MET SEQRES 14 A 316 ILE LEU ASN LYS PRO GLY LEU LYS TYR LYS PRO ALA VAL SEQRES 15 A 316 ASN GLN ILE GLU CYS HIS PRO TYR LEU THR GLN GLU LYS SEQRES 16 A 316 LEU ILE GLN TYR CYS GLN SER LYS GLY ILE VAL VAL THR SEQRES 17 A 316 ALA TYR SER PRO LEU GLY SER PRO ASP ARG PRO TRP ALA SEQRES 18 A 316 LYS PRO GLU ASP PRO SER LEU LEU GLU ASP PRO ARG ILE SEQRES 19 A 316 LYS ALA ILE ALA ALA LYS HIS ASN LYS THR THR ALA GLN SEQRES 20 A 316 VAL LEU ILE ARG PHE PRO MET GLN ARG ASN LEU VAL VAL SEQRES 21 A 316 ILE PRO LYS SER VAL THR PRO GLU ARG ILE ALA GLU ASN SEQRES 22 A 316 PHE LYS VAL PHE ASP PHE GLU LEU SER SER GLN ASP MET SEQRES 23 A 316 THR THR LEU LEU SER TYR ASN ARG ASN TRP ARG VAL CYS SEQRES 24 A 316 ALA LEU LEU SER CYS THR SER HIS LYS ASP TYR PRO PHE SEQRES 25 A 316 HIS GLU GLU PHE HET NAP A 401 48 HET 53N A 402 19 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM 53N 3-[5-(3-NITROPHENYL)THIOPHEN-2-YL]PROPANOIC ACID HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 2 NAP C21 H28 N7 O17 P3 FORMUL 3 53N C13 H11 N O4 S FORMUL 4 HOH *413(H2 O) HELIX 1 AA1 PRO A 23 GLY A 38 1 16 HELIX 2 AA2 ALA A 45 GLN A 49 5 5 HELIX 3 AA3 ASN A 50 GLU A 64 1 15 HELIX 4 AA4 LYS A 68 LEU A 72 5 5 HELIX 5 AA5 TRP A 79 HIS A 83 5 5 HELIX 6 AA6 GLU A 84 GLY A 86 5 3 HELIX 7 AA7 LEU A 87 LYS A 100 1 14 HELIX 8 AA8 ASN A 136 GLU A 150 1 15 HELIX 9 AA9 ASN A 162 ASN A 171 1 10 HELIX 10 AB1 GLN A 192 LYS A 202 1 11 HELIX 11 AB2 SER A 226 GLU A 229 5 4 HELIX 12 AB3 ASP A 230 HIS A 240 1 11 HELIX 13 AB4 THR A 243 GLN A 254 1 12 HELIX 14 AB5 THR A 265 LYS A 274 1 10 HELIX 15 AB6 SER A 281 SER A 290 1 10 HELIX 16 AB7 LEU A 300 THR A 304 5 5 SHEET 1 AA1 2 ARG A 3 LEU A 5 0 SHEET 2 AA1 2 LYS A 11 PRO A 13 -1 O MET A 12 N ILE A 4 SHEET 1 AA2 8 LEU A 17 GLY A 18 0 SHEET 2 AA2 8 HIS A 41 ASP A 43 1 O ASP A 43 N LEU A 17 SHEET 3 AA2 8 PHE A 73 LEU A 78 1 O VAL A 75 N ILE A 42 SHEET 4 AA2 8 LEU A 106 ILE A 109 1 O LEU A 108 N LEU A 78 SHEET 5 AA2 8 ILE A 156 SER A 159 1 O GLY A 157 N ILE A 109 SHEET 6 AA2 8 VAL A 181 GLU A 185 1 O VAL A 181 N ILE A 158 SHEET 7 AA2 8 VAL A 205 TYR A 209 1 O THR A 207 N ILE A 184 SHEET 8 AA2 8 VAL A 258 VAL A 259 1 O VAL A 258 N ALA A 208 SITE 1 AC1 34 GLY A 18 THR A 19 TRP A 20 LYS A 21 SITE 2 AC1 34 ASP A 43 TYR A 48 LYS A 77 HIS A 110 SITE 3 AC1 34 TRP A 111 SER A 159 ASN A 160 GLN A 183 SITE 4 AC1 34 TYR A 209 SER A 210 PRO A 211 LEU A 212 SITE 5 AC1 34 GLY A 213 SER A 214 PRO A 215 ASP A 216 SITE 6 AC1 34 ALA A 245 ILE A 260 PRO A 261 LYS A 262 SITE 7 AC1 34 SER A 263 VAL A 264 THR A 265 ARG A 268 SITE 8 AC1 34 GLU A 271 ASN A 272 53N A 402 HOH A 520 SITE 9 AC1 34 HOH A 579 HOH A 807 SITE 1 AC2 12 TRP A 20 TYR A 48 HIS A 110 TRP A 111 SITE 2 AC2 12 THR A 113 CYS A 298 ALA A 299 LEU A 300 SITE 3 AC2 12 CYS A 303 TYR A 309 NAP A 401 HOH A 527 CRYST1 49.449 66.354 47.429 90.00 92.31 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020223 0.000000 0.000815 0.00000 SCALE2 0.000000 0.015071 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021101 0.00000